Close Menu

NEW YORK (GenomeWeb) – SpeeDx said today that it has entered a test development collaboration with British drugmaker GlaxoSmithKline.

According to Sydney-based SpeeDx, it will provide GSK with a combination of existing and custom-developed molecular diagnostic tests to support its antibiotic clinical trials, as well as its new product development efforts.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.